Scinai Immunotherapeutics Ltd.
SCNI
$0.51
-$0.03-5.07%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.66M | 1.66M | 989.00K | 989.00K | 1.96M |
| Total Receivables | 168.00K | 168.00K | 139.00K | 139.00K | 217.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 75.00K | 75.00K | 236.00K | 236.00K | 79.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 150.00K | 150.00K | 142.00K | 142.00K | 131.00K |
| Total Current Assets | 2.05M | 2.05M | 1.51M | 1.51M | 2.39M |
|
|
|||||
| Total Current Assets | 2.05M | 2.05M | 1.51M | 1.51M | 2.39M |
| Net Property, Plant & Equipment | 9.57M | 9.57M | 10.33M | 10.33M | 11.06M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 11.63M | 11.63M | 11.84M | 11.84M | 13.45M |
|
|
|||||
| Total Accounts Payable | 407.00K | 407.00K | 659.00K | 659.00K | 376.00K |
| Total Accrued Expenses | 759.00K | 759.00K | -- | -- | 781.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 329.00K | 329.00K | 497.00K | 497.00K | 424.00K |
| Total Finance Division Other Current Liabilities | 90.00K | 90.00K | 964.00K | 964.00K | 225.00K |
| Total Other Current Liabilities | 90.00K | 90.00K | 964.00K | 964.00K | 225.00K |
| Total Current Liabilities | 1.59M | 1.59M | 2.12M | 2.12M | 1.81M |
|
|
|||||
| Total Current Liabilities | 1.59M | 1.59M | 2.12M | 2.12M | 1.81M |
| Long-Term Debt | 294.00K | 294.00K | 293.00K | 293.00K | 260.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.64M | 1.64M | 1.57M | 1.57M | 1.40M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | 3.00K | 3.00K | 3.00K |
| Total Liabilities | 3.52M | 3.52M | 3.98M | 3.98M | 3.47M |
|
|
|||||
| Common Stock & APIC | 130.06M | 130.06M | 125.64M | 125.64M | 123.63M |
| Retained Earnings | -125.85M | -125.85M | -121.67M | -121.67M | -117.54M |
| Treasury Stock & Other | -1.74M | -1.74M | -1.74M | -1.74M | -1.74M |
| Total Common Equity | 2.48M | 2.48M | 2.23M | 2.23M | 4.35M |
|
|
|||||
| Preferred Stock Redeemable | 5.63M | 5.63M | 5.63M | 5.63M | 5.63M |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 5.63M | 5.63M | 5.63M | 5.63M | 5.63M |
|
|
|||||
| Total Common Equity | 2.48M | 2.48M | 2.23M | 2.23M | 4.35M |
| Total Preferred Equity | 5.63M | 5.63M | 5.63M | 5.63M | 5.63M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 8.10M | 8.10M | 7.86M | 7.86M | 9.98M |
|
|
|||||